What is Guardian Research Network?
Guardian Research Network operates as a nationwide hospital consortium dedicated to the acceleration of medical breakthroughs. The company distinguishes itself through a secure, HIPAA-compliant data warehouse that serves as a foundational asset for advanced analytics. By streamlining patient identification and optimizing enrollment processes, the firm enables healthcare networks and life sciences entities to derive actionable insights from millions of patient records. This capability is critical for enhancing the efficacy of therapeutic and diagnostic studies, ultimately fostering a more inclusive and efficient clinical trial ecosystem.
How much funding has Guardian Research Network raised?
Guardian Research Network has raised a total of $1M across 2 funding rounds:
Debt
$350K
Debt
$665K
Debt (2020): $350K with participation from PPP
Debt (2021): $665K led by PPP
Key Investors in Guardian Research Network
PPP
Public-Private Partnership
What's next for Guardian Research Network?
With the recent influx of capital, Guardian Research Network is well-positioned to expand its footprint in the real-world evidence market. The strategic focus will likely shift toward enhancing the interoperability of its data analytics tools and deepening partnerships with major pharmaceutical developers. As the organization matures, the emphasis on scaling its technological architecture will be paramount to maintaining its competitive edge in patient-centric research. Future growth will depend on the firm's ability to translate complex longitudinal data into meaningful clinical outcomes, thereby solidifying its role as an essential intermediary in the global drug development pipeline.
See full Guardian Research Network company page
